{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:26:29Z","timestamp":1791919589564,"version":"4.3.4"},"reference-count":159,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1124\/jpet.119.256818","type":"journal-article","created":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T14:55:19Z","timestamp":1555599319000},"page":"111-126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":101,"title":["Cancer and the Dopamine D2 Receptor: A Pharmacological Perspective"],"prefix":"10.1016","volume":"370","author":[{"given":"Jillian S.","family":"Weissenrieder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey D.","family":"Neighbors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard B.","family":"Mailman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond J.","family":"Hohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.119.256818_bib1","first-page":"839","article-title":"Circumvention of multiple-drug resistance in human cancer cells by thioridazine, trifluoperazine, and chlorpromazine","volume":"76","author":"Akiyama","year":"1986","journal-title":"J Natl Cancer Inst"},{"key":"10.1124\/jpet.119.256818_bib2","doi-asserted-by":"crossref","first-page":"74380","DOI":"10.18632\/oncotarget.11814","article-title":"Discovery and clinical introduction of first-in-class imipridone ONC201","volume":"7","author":"Allen","year":"2016","journal-title":"Oncotarget"},{"key":"10.1124\/jpet.119.256818_bib3","doi-asserted-by":"crossref","first-page":"79298","DOI":"10.18632\/oncotarget.17837","article-title":"A phase 2 study of the first imipridone ONC201, a selective DRD2 antagonist for oncology, administered every three weeks in recurrent glioblastoma","volume":"8","author":"Arrillaga-Romany","year":"2017","journal-title":"Oncotarget"},{"key":"10.1124\/jpet.119.256818_bib4","doi-asserted-by":"crossref","first-page":"6896","DOI":"10.1016\/j.bmcl.2012.09.030","article-title":"Synthesis and biological evaluation of new phenothiazine derivatives bearing a pyrazole unit as protein farnesyltransferase inhibitors","volume":"22","author":"Baciu-Atudosie","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/jpet.119.256818_bib5","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1002\/cncr.21574","article-title":"Reduced cancer incidence among patients with schizophrenia","volume":"104","author":"Barak","year":"2005","journal-title":"Cancer"},{"key":"10.1124\/jpet.119.256818_bib6","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.tips.2007.02.006","article-title":"The Akt-GSK-3 signaling cascade in the actions of dopamine","volume":"28","author":"Beaulieu","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/jpet.119.256818_bib7","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1073\/pnas.0307921101","article-title":"Lithium antagonizes dopamine-dependent behaviors mediated by an AKT\/glycogen synthase kinase 3 signaling cascade","volume":"101","author":"Beaulieu","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.119.256818_bib8","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.parkreldis.2009.11.005","article-title":"Cancer risk in association with Parkinson disease: a population-based study","volume":"16","author":"Becker","year":"2010","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1124\/jpet.119.256818_bib9","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nature11691","article-title":"Automated design of ligands to polypharmacological profiles","volume":"492","author":"Besnard","year":"2012","journal-title":"Nature"},{"key":"10.1124\/jpet.119.256818_bib154","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/0024-3205(84)90540-X","article-title":"Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum","volume":"35","author":"Billard","year":"1984","journal-title":"Life Sci"},{"key":"10.1124\/jpet.119.256818_bib10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-3-642-25761-2_3","article-title":"Dopamine receptor signaling and current and future antipsychotic drugs","author":"Boyd","year":"2012","journal-title":"Handb Exp Pharmacol"},{"key":"10.1124\/jpet.119.256818_bib11","doi-asserted-by":"crossref","first-page":"8911","DOI":"10.1523\/JNEUROSCI.22-20-08911.2002","article-title":"Dopamine induces a PI3-kinase-independent activation of Akt in striatal neurons: a new route to cAMP response element-binding protein phosphorylation","volume":"22","author":"Brami-Cherrier","year":"2002","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.119.256818_bib12","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/336783a0","article-title":"Cloning and expression of a rat D2 dopamine receptor cDNA","volume":"336","author":"Bunzow","year":"1988","journal-title":"Nature"},{"key":"10.1124\/jpet.119.256818_bib13","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1124\/jpet.105.092155","article-title":"Intrinsic efficacy of antipsychotics at human D2, D3, and D4 dopamine receptors: identification of the clozapine metabolite N-desmethylclozapine as a D2\/D3 partial agonist","volume":"315","author":"Burstein","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.119.256818_bib14","first-page":"800","article-title":"Properties of [3H]haloperidol and [3H]dopamine binding associated with dopamine receptors in calf brain membranes","volume":"12","author":"Burt","year":"1976","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.119.256818_bib15","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.mvr.2012.09.006","article-title":"Anti-angiogenic effects of thioridazine involving the FAK-mTOR pathway","volume":"84","author":"Byun","year":"2012","journal-title":"Microvasc Res"},{"key":"10.1124\/jpet.119.256818_bib16","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1194\/jlr.M026948","article-title":"Atypical antipsychotics alter cholesterol and fatty acid metabolism in vitro","volume":"54","author":"Canfr\u00e1n-Duque","year":"2013","journal-title":"J Lipid Res"},{"key":"10.1124\/jpet.119.256818_bib17","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1600-0773.1963.tb01730.x","article-title":"Effect of chlorpromazine and haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain","volume":"20","author":"Carlsson","year":"1963","journal-title":"Acta Pharmacol Toxicol (Copenh)"},{"key":"10.1124\/jpet.119.256818_bib18","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1126\/science.127.3296.471.a","article-title":"On the presence of 3-hydroxytyramine in brain","volume":"127","author":"Carlsson","year":"1958","journal-title":"Science"},{"key":"10.1124\/jpet.119.256818_bib19","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1002\/ijc.30628","article-title":"Complementary actions of dopamine D2 receptor agonist and anti-vegf therapy on tumoral vessel normalization in a transgenic mouse model","volume":"140","author":"Chauvet","year":"2017","journal-title":"Int J Cancer"},{"key":"10.1124\/jpet.119.256818_bib20","doi-asserted-by":"crossref","first-page":"e1753","DOI":"10.1038\/cddis.2015.77","article-title":"Identification of thioridazine, an antipsychotic drug, as an antiglioblastoma and anticancer stem cell agent using public gene expression data","volume":"6","author":"Cheng","year":"2015","journal-title":"Cell Death Dis"},{"key":"10.1124\/jpet.119.256818_bib21","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1002\/jcp.25277","article-title":"Genetic polymorphism of CHRM2 in COPD: clinical significance and therapeutic implications","volume":"231","author":"Cherubini","year":"2016","journal-title":"J Cell Physiol"},{"key":"10.1124\/jpet.119.256818_bib22","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0924-977X(98)00005-4","article-title":"The use of a side effect as a qualitative indicator of plasma chlorpromazine levels","volume":"9","author":"Chetty","year":"1999","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1124\/jpet.119.256818_bib23","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/343266a0","article-title":"A second molecular form of D2 dopamine receptor in rat and bovine caudate nucleus","volume":"343","author":"Chio","year":"1990","journal-title":"Nature"},{"key":"10.1124\/jpet.119.256818_bib24","doi-asserted-by":"crossref","first-page":"9831","DOI":"10.1007\/s13277-014-2278-1","article-title":"Thioridazine specifically sensitizes drug-resistant cancer cells through highly increase in apoptosis and P-gp inhibition","volume":"35","author":"Choi","year":"2014","journal-title":"Tumour Biol"},{"key":"10.1124\/jpet.119.256818_bib25","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1196\/annals.1414.041","article-title":"Potential inhibition of PDK1\/Akt signaling by phenothiazines suppresses cancer cell proliferation and survival","volume":"1138","author":"Choi","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1124\/jpet.119.256818_bib26","first-page":"5083","article-title":"Linkage analysis of DRD2, a marker linked to the ataxia-telangiectasia gene, in 64 families with premenopausal bilateral breast cancer","volume":"53","author":"Cortessis","year":"1993","journal-title":"Cancer Res"},{"key":"10.1124\/jpet.119.256818_bib27","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1126\/science.3854","article-title":"Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs","volume":"192","author":"Creese","year":"1976","journal-title":"Science"},{"key":"10.1124\/jpet.119.256818_bib28","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0140-6736(72)92955-8","article-title":"Chlorpromazines and cancer","volume":"2","author":"Csatary","year":"1972","journal-title":"Lancet"},{"key":"10.1124\/jpet.119.256818_bib29","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s002100000217","article-title":"[3H]S33084: a novel, selective and potent radioligand at cloned, human dopamine D3 receptors","volume":"361","author":"Cussac","year":"2000","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1124\/jpet.119.256818_bib30","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.bbrc.2005.01.028","article-title":"Chlorimipramine: a novel anticancer agent with a mitochondrial target","volume":"328","author":"Daley","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/jpet.119.256818_bib31","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1002\/j.1460-2075.1989.tb08585.x","article-title":"The dopamine D2 receptor: two molecular forms generated by alternative splicing","volume":"8","author":"Dal Toso","year":"1989","journal-title":"EMBO J"},{"key":"10.1124\/jpet.119.256818_bib32","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1042\/bj0720204","article-title":"The effect of chlorpromazine on the respiratory chain; cytochrome oxidase","volume":"72","author":"Dawkins","year":"1959","journal-title":"Biochem J"},{"key":"10.1124\/jpet.119.256818_bib33","first-page":"104","article-title":"Neuroleptic effects of chlorpromazine in therapeutics of neuropsychiatry","volume":"16","author":"Delay","year":"1955","journal-title":"J Clin Exp Psychopathol"},{"key":"10.1124\/jpet.119.256818_bib34","first-page":"398","article-title":"[N-dimethylamino-prophylchlorophenothiazine (4560 RP) therapy of confusional states]","volume":"110","author":"Delay","year":"1952","journal-title":"Ann Med Psychol (Paris)"},{"key":"10.1124\/jpet.119.256818_bib35","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/syn.20851","article-title":"Antipsychotic-induced DRD2 upregulation and its prevention by \u03b1-lipoic acid in SH-SY5Y neuroblastoma cells","volume":"65","author":"Deslauriers","year":"2011","journal-title":"Synapse"},{"key":"10.1124\/jpet.119.256818_bib36","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.ccell.2016.05.002","article-title":"Inhibition of dopamine receptor D4 impedes autophagic flux, proliferation, and survival of glioblastoma stem cells","volume":"29","author":"Dolma","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1124\/jpet.119.256818_bib37","first-page":"45","article-title":"Psychotropic drugs as potential antitumor agents: a selective screening study","volume":"62","author":"Driscoll","year":"1978","journal-title":"Cancer Treat Rep"},{"key":"10.1124\/jpet.119.256818_bib38","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1158\/1055-9965.EPI-07-0038","article-title":"A prospective cohort study of cancer incidence following the diagnosis of Parkinson\u2019s disease","volume":"16","author":"Driver","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1124\/jpet.119.256818_bib39","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/schbul\/18.2.217","article-title":"Long-term course of hospitalization for schizophrenia: part I. Risk for rehospitalization","volume":"18","author":"Eaton","year":"1992","journal-title":"Schizophr Bull"},{"key":"10.1124\/jpet.119.256818_bib40","first-page":"1015","article-title":"[Favorable course in carcinoma patients due to additional phenothiazine therapy]","volume":"68","author":"Eicke","year":"1973","journal-title":"Med Klin"},{"key":"10.1124\/jpet.119.256818_bib41","doi-asserted-by":"crossref","first-page":"9896575","DOI":"10.1155\/2016\/9896575","article-title":"Potential antioxidant activity of new tetracyclic and pentacyclic nonlinear phenothiazine derivatives","volume":"2016","author":"Engwa","year":"2016","journal-title":"Biochem Res Int"},{"key":"10.1124\/jpet.119.256818_bib42","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/0306-3623(94)90357-3","article-title":"Interaction of permanently charged metoclopramide analogs with D-2 dopamine receptors","volume":"25","author":"Farooqui","year":"1994","journal-title":"Gen Pharmacol"},{"key":"10.1124\/jpet.119.256818_bib43","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1471-2202-7-69","article-title":"Drug-induced activation of SREBP-controlled lipogenic gene expression in CNS-related cell lines: marked differences between various antipsychotic drugs","volume":"7","author":"Fern\u00f8","year":"2006","journal-title":"BMC Neurosci"},{"key":"10.1124\/jpet.119.256818_bib44","doi-asserted-by":"crossref","first-page":"396","DOI":"10.2165\/00003088-198917060-00004","article-title":"Pharmacokinetics of haloperidol","volume":"17","author":"Froemming","year":"1989","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/jpet.119.256818_bib45","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/0024-3205(78)90102-9","article-title":"Dopamine receptors: pharmacological and anatomical evidences indicate that two distinct dopamine receptor populations are present in rat striatum","volume":"23","author":"Garau","year":"1978","journal-title":"Life Sci"},{"key":"10.1124\/jpet.119.256818_bib47","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1016\/j.bmc.2016.04.001","article-title":"Studies on phenothiazines: new microtubule-interacting compounds with phenothiazine A-ring as potent antineoplastic agents","volume":"24","author":"Ghinet","year":"2016","journal-title":"Bioorg Med Chem"},{"key":"10.1124\/jpet.119.256818_bib48","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1385\/JMN:22:3:189","article-title":"Characterization of phenothiazine-induced apoptosis in neuroblastoma and glioma cell lines: clinical relevance and possible application for brain-derived tumors","volume":"22","author":"Gil-Ad","year":"2004","journal-title":"J Mol Neurosci"},{"key":"10.1124\/jpet.119.256818_bib49","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/342923a0","article-title":"Alternative splicing directs the expression of two D2 dopamine receptor isoforms","volume":"342","author":"Giros","year":"1989","journal-title":"Nature"},{"key":"10.1124\/jpet.119.256818_bib50","doi-asserted-by":"crossref","first-page":"9762","DOI":"10.1073\/pnas.86.24.9762","article-title":"Cloning of the cDNA and gene for a human D2 dopamine receptor","volume":"86","author":"Grandy","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.119.256818_bib51","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/00004714-199812000-00010","article-title":"Multiple-dose pharmacokinetics of clozapine in patients with chronic schizophrenia","volume":"18","author":"Guitton","year":"1998","journal-title":"J Clin Psychopharmacol"},{"key":"10.1124\/jpet.119.256818_bib52","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1192\/S0007125000297080","article-title":"Cancer incidence of schizophrenic patients. Results of record linkage studies in three countries","author":"Gulbinat","year":"1992","journal-title":"Br J Psychiatry Suppl"},{"key":"10.1124\/jpet.119.256818_bib53","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1172\/JCI65093","article-title":"Phenothiazines induce PP2A-mediated apoptosis in T cell acute lymphoblastic leukemia","volume":"124","author":"Gutierrez","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.119.256818_bib54","first-page":"63","article-title":"Urinary isatin concentrations in patients with Parkinson\u2019s disease determined by a newly developed HPLC-UV method","volume":"108","author":"Hamaue","year":"2000","journal-title":"Res Commun Mol Pathol Pharmacol"},{"key":"10.1124\/jpet.119.256818_bib55","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0140-6736(88)90202-4","article-title":"Thioridazine: a radiation enhancer in advanced cervical cancer?","volume":"2","author":"Hercbergs","year":"1988","journal-title":"Lancet"},{"key":"10.1124\/jpet.119.256818_bib56","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s40264-017-0543-0","article-title":"Second-generation antipsychotics and metabolic side effects: a systematic review of population-based studies","volume":"40","author":"Hirsch","year":"2017","journal-title":"Drug Saf"},{"key":"10.1124\/jpet.119.256818_bib57","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.molonc.2014.08.008","article-title":"Dopamine D2 receptor agonists inhibit lung cancer progression by reducing angiogenesis and tumor infiltrating myeloid derived suppressor cells","volume":"9","author":"Hoeppner","year":"2015","journal-title":"Mol Oncol"},{"key":"10.1124\/jpet.119.256818_bib58","first-page":"528","article-title":"The complex inter-relationship between diabetes and schizophrenia","volume":"13","author":"Hoffman","year":"2017","journal-title":"Curr Diabetes Rev"},{"key":"10.1124\/jpet.119.256818_bib59","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.canlet.2017.03.015","article-title":"The dopamine D3 receptor antagonists PG01037, NGB2904, SB277011A, and U99194 reverse ABCG2 transporter-mediated drug resistance in cancer cell lines","volume":"396","author":"Hussein","year":"2017","journal-title":"Cancer Lett"},{"key":"10.1124\/jpet.119.256818_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10090308","article-title":"Cariprazine, a dopamine D2\/D3 receptor partial agonist, modulates ABCG2-mediated multidrug resistance in cancer","volume":"10","author":"Hussein","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1124\/jpet.119.256818_bib61","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/bjc.1992.71","article-title":"Enhancement of dopaminergic agonist bromocriptine of gastric carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in Wistar rats","volume":"65","author":"Iishi","year":"1992","journal-title":"Br J Cancer"},{"key":"10.1124\/jpet.119.256818_bib62","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1007\/s00213-016-4428-1","article-title":"Plasma levels and estimated dopamine D2 receptor occupancy of long-acting injectable risperidone during maintenance treatment of schizophrenia: a 3-year follow-up study","volume":"233","author":"Ikai","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.119.256818_bib63","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/bmj.2.5963.141-b","article-title":"Letter: prolactin studies, pituitary tumour, and reproductive function","volume":"2","author":"Jacobs","year":"1975","journal-title":"BMJ"},{"key":"10.1124\/jpet.119.256818_bib64","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0165-1161(91)90125-R","article-title":"Treatment of mice with a herbal preparation (Liv. 52) reduces the frequency of radiation-induced chromosome damage in bone marrow","volume":"253","author":"Jagetia","year":"1991","journal-title":"Mutat Res"},{"key":"10.1124\/jpet.119.256818_bib65","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1053\/j.gastro.2016.08.040","article-title":"Expression of DRD2 is increased in human pancreatic ductal adenocarcinoma and inhibitors slow tumor growth in mice","volume":"151","author":"Jandaghi","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1124\/jpet.119.256818_bib66","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/ana.410170514","article-title":"Low cancer rates among patients with Parkinson\u2019s disease","volume":"17","author":"Jansson","year":"1985","journal-title":"Ann Neurol"},{"key":"10.1124\/jpet.119.256818_bib67","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/glia.23103","article-title":"Dopamine elevates and lowers astroglial Ca2+ through distinct pathways depending on local synaptic circuitry","volume":"65","author":"Jennings","year":"2017","journal-title":"Glia"},{"key":"10.1124\/jpet.119.256818_bib68","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.canep.2016.11.002","article-title":"Parkinson\u2019s disease and risk of prostate cancer: a Danish population-based case-control study, 1995-2010","volume":"45","author":"Jespersen","year":"2016","journal-title":"Cancer Epidemiol"},{"key":"10.1124\/jpet.119.256818_bib69","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000381061","article-title":"Expression of somatostatin receptors 1-5 and dopamine receptor 2 in lung carcinoids: implications for a therapeutic role","volume":"101","author":"Kanakis","year":"2015","journal-title":"Neuroendocrinology"},{"key":"10.1124\/jpet.119.256818_bib70","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s10495-012-0717-2","article-title":"Thioridazine induces apoptosis by targeting the PI3K\/Akt\/mTOR pathway in cervical and endometrial cancer cells","volume":"17","author":"Kang","year":"2012","journal-title":"Apoptosis"},{"key":"10.1124\/jpet.119.256818_bib71","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11060-014-1688-7","article-title":"Olanzapine inhibits proliferation, migration and anchorage-independent growth in human glioblastoma cell lines and enhances temozolomide\u2019s antiproliferative effect","volume":"122","author":"Karpel-Massler","year":"2015","journal-title":"J Neurooncol"},{"key":"10.1124\/jpet.119.256818_bib72","first-page":"81","article-title":"Disposition and biotransformation of the antipsychotic agent olanzapine in humans","volume":"25","author":"Kassahun","year":"1997","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.119.256818_bib73","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S1535-6108(03)00303-9","article-title":"A chemical genetic screen identifies inhibitors of regulated nuclear export of a Forkhead transcription factor in PTEN-deficient tumor cells","volume":"4","author":"Kau","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1124\/jpet.119.256818_bib74","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/277093a0","article-title":"Multiple receptors for dopamine","volume":"277","author":"Kebabian","year":"1979","journal-title":"Nature"},{"key":"10.1124\/jpet.119.256818_bib75","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0378-4347(97)00152-7","article-title":"Sensitive assay for pimozide in human plasma using high-performance liquid chromatography with fluorescence detection: application to pharmacokinetic studies","volume":"694","author":"Kerbusch","year":"1997","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"10.1124\/jpet.119.256818_bib76","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/jnr.10426","article-title":"Protective effect of dopamine D2 agonists in cortical neurons via the phosphatidylinositol 3 kinase cascade","volume":"70","author":"Kihara","year":"2002","journal-title":"J Neurosci Res"},{"key":"10.1124\/jpet.119.256818_bib77","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.neo.2017.10.002","article-title":"Role of dopamine receptors in the anticancer activity of ONC201","volume":"20","author":"Kline","year":"2018","journal-title":"Neoplasia"},{"key":"10.1124\/jpet.119.256818_bib78","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/tpj.2009.62","article-title":"Antipsychotic drugs upregulate lipogenic gene expression by disrupting intracellular trafficking of lipoprotein-derived cholesterol","volume":"10","author":"Kristiana","year":"2010","journal-title":"Pharmacogenomics J"},{"key":"10.1124\/jpet.119.256818_bib79","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/sj.npp.1300027","article-title":"H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs","volume":"28","author":"Kroeze","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.119.256818_bib155","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0893-133X(98)00099-2","article-title":"Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes","volume":"20","author":"Lawler","year":"1999","journal-title":"Neuropsychopharmacol"},{"key":"10.1124\/jpet.119.256818_bib80","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.neuropharm.2014.05.042","article-title":"SKF-83959 is not a highly-biased functionally selective D1 dopamine receptor ligand with activity at phospholipase C","volume":"86","author":"Lee","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.119.256818_bib81","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1124\/jpet.114.214411","article-title":"Dopamine D1 receptor signaling: does G\u03b1Q-phospholipase C actually play a role?","volume":"351","author":"Lee","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.119.256818_bib82","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1080\/15548627.2017.1328347","article-title":"Activation of DRD5 (dopamine receptor D5) inhibits tumor growth by autophagic cell death","volume":"13","author":"Leng","year":"2017","journal-title":"Autophagy"},{"key":"10.1124\/jpet.119.256818_bib83","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1385\/JMN:27:1:029","article-title":"Differential induction of apoptosis by antidepressants in glioma and neuroblastoma cell lines: evidence for p-c-Jun, cytochrome c, and caspase-3 involvement","volume":"27","author":"Levkovitz","year":"2005","journal-title":"J Mol Neurosci"},{"key":"10.1124\/jpet.119.256818_bib84","doi-asserted-by":"crossref","first-page":"882","DOI":"10.18632\/oncotarget.1801","article-title":"Genome-wide shRNA screen revealed integrated mitogenic signaling between dopamine receptor D2 (DRD2) and epidermal growth factor receptor (EGFR) in glioblastoma","volume":"5","author":"Li","year":"2014","journal-title":"Oncotarget"},{"key":"10.1124\/jpet.119.256818_bib85","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1007\/s00268-006-0035-3","article-title":"DRD2\/DARPP-32 expression correlates with lymph node metastasis and tumor progression in patients with esophageal squamous cell carcinoma","volume":"30","author":"Li","year":"2006","journal-title":"World J Surg"},{"key":"10.1124\/jpet.119.256818_bib86","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1001\/archpsyc.58.6.573","article-title":"Incidence of cancer among persons with schizophrenia and their relatives","volume":"58","author":"Lichtermann","year":"2001","journal-title":"Arch Gen Psychiatry"},{"key":"10.1124\/jpet.119.256818_bib87","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2210-9-13","article-title":"Spiperone enhances intracellular calcium level and inhibits the Wnt signaling pathway","volume":"9","author":"Lu","year":"2009","journal-title":"BMC Pharmacol"},{"key":"10.1124\/jpet.119.256818_bib88","first-page":"1582","article-title":"Parkinson\u2019s disease and D1 dopamine receptors","volume":"2","author":"Mailman","year":"2001","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1124\/jpet.119.256818_bib89","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.tips.2007.06.002","article-title":"GPCR functional selectivity has therapeutic impact","volume":"28","author":"Mailman","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/jpet.119.256818_bib90","series-title":"Parkinson\u2019s Disease and Related Disorders, Part 1","first-page":"77","article-title":"Dopamine receptor pharmacology","author":"Mailman","year":"2007"},{"key":"10.1124\/jpet.119.256818_bib91","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1124\/mol.110.065409","article-title":"Signaling pathways leading to phosphorylation of Akt and GSK-3\u03b2 by activation of cloned human and rat cerebral D2and D3 receptors","volume":"79","author":"Mannoury la Cour","year":"2011","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.119.256818_bib92","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1111\/jog.12691","article-title":"Dopamine D2 receptor blocker thioridazine induces cell death in human uterine cervical carcinoma cell line SiHa","volume":"41","author":"Mao","year":"2015","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1124\/jpet.119.256818_bib93","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/jnr.490310112","article-title":"Calmodulin antagonists chlorpromazine and W-7 inhibit exogenous cholesterol esterification and sphingomyelinase activity in human skin fibroblast cultures. Similarities between drug-induced and Niemann-Pick type C lipidoses","volume":"31","author":"Masson","year":"1992","journal-title":"J Neurosci Res"},{"key":"10.1124\/jpet.119.256818_bib94","first-page":"2767","article-title":"The important application of thioridazine in the endometrial cancer","volume":"8","author":"Meng","year":"2016","journal-title":"Am J Transl Res"},{"key":"10.1124\/jpet.119.256818_bib158","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0022-3565(24)29415-5","article-title":"S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine","volume":"298","author":"Millan","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.119.256818_bib95","doi-asserted-by":"crossref","first-page":"e1063","DOI":"10.1038\/cddis.2014.35","article-title":"Antipsychotic agent thioridazine sensitizes renal carcinoma Caki cells to TRAIL-induced apoptosis through reactive oxygen species-mediated inhibition of Akt signaling and downregulation of Mcl-1 and c-FLIP(L)","volume":"5","author":"Min","year":"2014","journal-title":"Cell Death Dis"},{"key":"10.1124\/jpet.119.256818_bib96","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1136\/bmj.310.6993.1500","article-title":"Occurrence of different cancers in patients with Parkinson\u2019s disease","volume":"310","author":"M\u00f8ller","year":"1995","journal-title":"BMJ"},{"key":"10.1124\/jpet.119.256818_bib97","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/0006-8993(89)90915-3","article-title":"Identification and characterization of D1 and D2 dopamine receptors in cultured neuroblastoma and retinoblastoma clonal cell lines","volume":"492","author":"Monsma","year":"1989","journal-title":"Brain Res"},{"key":"10.1124\/jpet.119.256818_bib98","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/342926a0","article-title":"Multiple D2 dopamine receptors produced by alternative RNA splicing","volume":"342","author":"Monsma","year":"1989","journal-title":"Nature"},{"key":"10.1124\/jpet.119.256818_bib99","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1158\/1078-0432.CCR-10-2441","article-title":"Dopamine blocks stress-mediated ovarian carcinoma growth","volume":"17","author":"Moreno-Smith","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1124\/jpet.119.256818_bib100","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0920-9964(94)90028-0","article-title":"The occurrence of cancer in first admitted schizophrenic patients","volume":"12","author":"Mortensen","year":"1994","journal-title":"Schizophr Res"},{"key":"10.1124\/jpet.119.256818_bib101","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.3892\/or.2014.3068","article-title":"Thioridazine, an antipsychotic drug, elicits potent antitumor effects in gastric cancer","volume":"31","author":"Mu","year":"2014","journal-title":"Oncol Rep"},{"key":"10.1124\/jpet.119.256818_bib102","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1600-0447.1989.tb10275.x","article-title":"Schizophrenia: a 13-year follow-up. Diagnostic and psychopathological aspects","volume":"79","author":"Munk-J\u00f8rgensen","year":"1989","journal-title":"Acta Psychiatr Scand"},{"key":"10.1124\/jpet.119.256818_bib103","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.ccr.2012.11.002","article-title":"Pharmacologic inhibition of MALT1 protease by phenothiazines as a therapeutic approach for the treatment of aggressive ABC-DLBCL","volume":"22","author":"Nagel","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1124\/jpet.119.256818_bib104","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2147\/DDDT.S95100","article-title":"Clinical pharmacology study of cariprazine (MP-214) in patients with schizophrenia (12-week treatment)","volume":"10","author":"Nakamura","year":"2016","journal-title":"Drug Des Devel Ther"},{"key":"10.1124\/jpet.119.256818_bib105","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1182\/blood-2009-11-255232","article-title":"The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors","volume":"117","author":"Nelson","year":"2011","journal-title":"Blood"},{"key":"10.1124\/jpet.119.256818_bib106","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0014-2999(03)02008-9","article-title":"Receptor affinities of dopamine D1 receptor-selective novel phenylbenzazepines","volume":"474","author":"Neumeyer","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.119.256818_bib107","series-title":"The Dopamine Receptors","author":"Neve","year":"1997"},{"key":"10.1124\/jpet.119.256818_bib108","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1124\/jpet.102.039875","article-title":"Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. II. Agonist and antagonist properties at subtypes of dopamine D(2)-like receptor and alpha(1)\/alpha(2)-adrenoceptor","volume":"303","author":"Newman-Tancredi","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.119.256818_bib109","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3109\/08039486109167943","article-title":"[Has chlorpromazine a cytostatic effect? A few reflections in connection with a case and the modern literature]","volume":"15","author":"Osterman","year":"1961","journal-title":"Nord Psykiatr Tidsskr"},{"key":"10.1124\/jpet.119.256818_bib110","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.18632\/oncotarget.2063","article-title":"Thioridazine inhibits angiogenesis and tumor growth by targeting the VEGFR-2\/PI3K\/mTOR pathway in ovarian cancer xenografts","volume":"5","author":"Park","year":"2014","journal-title":"Oncotarget"},{"key":"10.1124\/jpet.119.256818_bib111","doi-asserted-by":"crossref","first-page":"42110","DOI":"10.18632\/oncotarget.9881","article-title":"Pharmacological activation of FOXO3 suppresses triple-negative breast cancer in vitro and in vivo","volume":"7","author":"Park","year":"2016","journal-title":"Oncotarget"},{"key":"10.1124\/jpet.119.256818_bib112","doi-asserted-by":"crossref","first-page":"10339","DOI":"10.7314\/APJCP.2014.15.23.10339","article-title":"Dopamine receptor gene (DRD1-DRD5) expression changes as stress factors associated with breast cancer","volume":"15","author":"Pornour","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1124\/jpet.119.256818_bib113","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1158\/1078-0432.CCR-18-2572","article-title":"Dopamine receptor D5 is a modulator of tumor response to dopamine receptor D2 antagonism","volume":"25","author":"Prabhu","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1124\/jpet.119.256818_bib114","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1021\/jm200436t","article-title":"N-benzoylated phenoxazines and phenothiazines: synthesis, antiproliferative activity, and inhibition of tubulin polymerization","volume":"54","author":"Prinz","year":"2011","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.119.256818_bib115","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1007\/s11427-013-4561-6","article-title":"Potential antitumor mechanisms of phenothiazine drugs","volume":"56","author":"Qi","year":"2013","journal-title":"Sci China Life Sci"},{"key":"10.1124\/jpet.119.256818_bib116","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1158\/0008-5472.CAN-15-1233","article-title":"Penfluridol: an antipsychotic agent suppresses metastatic tumor growth in triple-negative breast cancer by inhibiting integrin signaling axis","volume":"76","author":"Ranjan","year":"2016","journal-title":"Cancer Res"},{"key":"10.1124\/jpet.119.256818_bib117","doi-asserted-by":"crossref","first-page":"26165","DOI":"10.1038\/srep26165","article-title":"Penfluridol suppresses pancreatic tumor growth by autophagy-mediated apoptosis","volume":"6","author":"Ranjan","year":"2016","journal-title":"Sci Rep"},{"key":"10.1124\/jpet.119.256818_bib118","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ygyno.2010.10.003","article-title":"A gene signature-based approach identifies thioridazine as an inhibitor of phosphatidylinositol-3\u2032-kinase (PI3K)\/AKT pathway in ovarian cancer cells","volume":"120","author":"Rho","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1124\/jpet.119.256818_bib156","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/BF02311185","article-title":"D4 dopamine receptor binding affinity does not distinguish between typical and atypical antipsychotic drugs","volume":"120","author":"Roth","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.119.256818_bib119","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.cell.2012.03.049","article-title":"Identification of drugs including a dopamine receptor antagonist that selectively target cancer stem cells","volume":"149","author":"Sachlos","year":"2012","journal-title":"Cell"},{"key":"10.1124\/jpet.119.256818_bib120","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neuroscience.2010.01.051","article-title":"Haloperidol disrupts lipid rafts and impairs insulin signaling in SH-SY5Y cells","volume":"167","author":"S\u00e1nchez-Wandelmer","year":"2010","journal-title":"Neuroscience"},{"key":"10.1124\/jpet.119.256818_bib121","series-title":"Drug Discovery and Development","article-title":"The role of DRD2 in cancer","author":"Schalop","year":"2016"},{"key":"10.1124\/jpet.119.256818_bib122","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/jcbfm.1992.114","article-title":"Errors introduced by tissue heterogeneity in estimation of local cerebral glucose utilization with current kinetic models of the [18F]fluorodeoxyglucose method","volume":"12","author":"Schmidt","year":"1992","journal-title":"J Cereb Blood Flow Metab"},{"issue":"Suppl 3","key":"10.1124\/jpet.119.256818_bib157","first-page":"5","article-title":"Therapeutic receptor-blocking concentrations of neuroleptics","volume":"10","author":"Seeman","year":"1995","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1124\/jpet.119.256818_bib123","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0893-133X(96)00187-X","article-title":"Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors","volume":"16","author":"Seeman","year":"1997","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.119.256818_bib124","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/261717a0","article-title":"Antipsychotic drug doses and neuroleptic\/dopamine receptors","volume":"261","author":"Seeman","year":"1976","journal-title":"Nature"},{"key":"10.1124\/jpet.119.256818_bib125","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1038\/sj.npp.1300203","article-title":"Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology","volume":"28","author":"Shapiro","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.119.256818_bib126","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ccell.2015.08.012","article-title":"Dual targeting of the autophagic regulatory circuitry in gliomas with repurposed drugs elicits cell-lethal autophagy and therapeutic benefit","volume":"28","author":"Shchors","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1124\/jpet.119.256818_bib127","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1248\/bpb.b12-00009","article-title":"Sertindole, a potent antagonist at dopamine D2 receptors, induces autophagy by increasing reactive oxygen species in SH-SY5Y neuroblastoma cells","volume":"35","author":"Shin","year":"2012","journal-title":"Biol Pharm Bull"},{"key":"10.1124\/jpet.119.256818_bib128","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1093\/carcin\/bgt169","article-title":"The antipsychotic agent chlorpromazine induces autophagic cell death by inhibiting the Akt\/mTOR pathway in human U-87MG glioma cells","volume":"34","author":"Shin","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1124\/jpet.119.256818_bib129","first-page":"607","article-title":"[Utilization of the neuroplegic properties of chloro-3-(dimethylamino-3\u2032-propyl)-10-phenothiazine hydrochloride (R.P. 4560) in neuropsychiatric therapy]","volume":"61","author":"Sigwald","year":"1953","journal-title":"Presse Med"},{"key":"10.1124\/jpet.119.256818_bib130","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0165-1781(84)90045-3","article-title":"Plasma and red cell levels of thioridazine and clinical response in schizophrenia","volume":"12","author":"Smith","year":"1984","journal-title":"Psychiatry Res"},{"key":"10.1124\/jpet.119.256818_bib131","doi-asserted-by":"crossref","first-page":"e271","DOI":"10.1371\/journal.pbio.0030271","article-title":"Dopamine-independent locomotor actions of amphetamines in a novel acute mouse model of Parkinson disease","volume":"3","author":"Sotnikova","year":"2005","journal-title":"PLoS Biol"},{"key":"10.1124\/jpet.119.256818_bib132","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s00726-017-2408-3","article-title":"Validation of dopamine receptor DRD1 and DRD2 antibodies using receptor deficient mice","volume":"49","author":"Stojanovic","year":"2017","journal-title":"Amino Acids"},{"key":"10.1124\/jpet.119.256818_bib133","first-page":"5399","article-title":"Inhibition of human breast cancer cell proliferation in tissue culture by the neuroleptic agents pimozide and thioridazine","volume":"50","author":"Strobl","year":"1990","journal-title":"Cancer Res"},{"key":"10.1124\/jpet.119.256818_bib134","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/350614a0","article-title":"Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1","volume":"350","author":"Sunahara","year":"1991","journal-title":"Nature"},{"key":"10.1124\/jpet.119.256818_bib135","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1017\/S146114571100109X","article-title":"The dopamine D2 receptor regulates Akt and GSK-3 via Dvl-3","volume":"15","author":"Sutton","year":"2012","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1124\/jpet.119.256818_bib136","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.21873\/anticanres.11085","article-title":"Aripiprazole, an antipsychotic and partial dopamine agonist, inhibits cancer stem cells and reverses chemoresistance","volume":"36","author":"Suzuki","year":"2016","journal-title":"Anticancer Res"},{"key":"10.1124\/jpet.119.256818_bib159","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0022-3565(25)38500-9","article-title":"Pharmacological and functional characterization of D2, D3 and D4 dopamine receptors in fibroblast and dopaminergic cell lines","volume":"268","author":"Tang","year":"1994","journal-title":"J Pharmacol Exper Ther"},{"key":"10.1124\/jpet.119.256818_bib137","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0014-2999(91)90508-N","article-title":"Dihydrexidine, a full dopamine D1 agonist, reduces MPTP-induced parkinsonism in monkeys","volume":"199","author":"Taylor","year":"1991","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.119.256818_bib138","first-page":"440","article-title":"Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications","volume":"178","author":"Toll","year":"1998","journal-title":"NIDA Res Monogr"},{"key":"10.1124\/jpet.119.256818_bib160","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/350610a0","article-title":"Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine","volume":"350","author":"Van Tol","year":"1991","journal-title":"Nature"},{"key":"10.1124\/jpet.119.256818_bib139","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2210-9-10","article-title":"Psychotropic drugs up-regulate the expression of cholesterol transport proteins including ApoE in cultured human CNS- and liver cells","volume":"9","author":"Vik-Mo","year":"2009","journal-title":"BMC Pharmacol"},{"key":"10.1124\/jpet.119.256818_bib140","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ccell.2016.09.008","article-title":"An LXR-cholesterol Axis creates a metabolic Co-dependency for brain cancers","volume":"30","author":"Villa","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1124\/jpet.119.256818_bib141","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.parkreldis.2014.10.015","article-title":"Cancer risks among the users of ergot-derived dopamine agonists for Parkinson\u2019s disease, a nationwide population-based survey","volume":"21","author":"Wang","year":"2015","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1124\/jpet.119.256818_bib142","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1046\/j.1471-4159.1999.0732375.x","article-title":"Dopamine D2 receptor isoforms expressed in AtT20 cells differentially couple to G proteins to acutely inhibit high voltage-activated calcium channels","volume":"73","author":"Wolfe","year":"1999","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.119.256818_bib143","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.schres.2013.01.036","article-title":"Validation of the Taiwanese Mandarin version of the Personal and Social Performance scale in a sample of 655 stable schizophrenic patients","volume":"146","author":"Wu","year":"2013","journal-title":"Schizophr Res"},{"key":"10.1124\/jpet.119.256818_bib144","doi-asserted-by":"crossref","first-page":"27540","DOI":"10.1038\/srep27540","article-title":"Pharmacological exploitation of the phenothiazine antipsychotics to develop novel antitumor agents-A drug repurposing strategy","volume":"6","author":"Wu","year":"2016","journal-title":"Sci Rep"},{"key":"10.1124\/jpet.119.256818_bib145","doi-asserted-by":"crossref","first-page":"11607","DOI":"10.1073\/pnas.96.20.11607","article-title":"D(2) dopamine receptors induce mitogen-activated protein kinase and cAMP response element-binding protein phosphorylation in neurons","volume":"96","author":"Yan","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.119.256818_bib146","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1164\/rccm.201207-1180OC","article-title":"Trifluoperazine, an antipsychotic agent, inhibits cancer stem cell growth and overcomes drug resistance of lung cancer","volume":"186","author":"Yeh","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1124\/jpet.119.256818_bib147","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.3892\/mmr.2015.3967","article-title":"Dopamine receptor antagonist thioridazine inhibits tumor growth in a murine breast cancer model","volume":"12","author":"Yin","year":"2015","journal-title":"Mol Med Rep"},{"key":"10.1124\/jpet.119.256818_bib148","doi-asserted-by":"crossref","first-page":"28435","DOI":"10.1074\/jbc.M113.461202","article-title":"Dopamine D2 receptor-mediated epidermal growth factor receptor transactivation through a disintegrin and metalloprotease regulates dopaminergic neuron development via extracellular signal-related kinase activation","volume":"288","author":"Yoon","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.119.256818_bib149","doi-asserted-by":"crossref","first-page":"15641","DOI":"10.1074\/jbc.M110.188078","article-title":"Wnt5a-dopamine D2 receptor interactions regulate dopamine neuron development via extracellular signal-regulated kinase (ERK) activation","volume":"286","author":"Yoon","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.119.256818_bib150","doi-asserted-by":"crossref","first-page":"6709828","DOI":"10.1155\/2016\/6709828","article-title":"Targeting lung cancer stem cells with antipsychological drug thioridazine","volume":"2016","author":"Yue","year":"2016","journal-title":"BioMed Res Int"},{"key":"10.1124\/jpet.119.256818_bib151","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00280-003-0738-1","article-title":"Phenothiazines suppress proliferation and induce apoptosis in cultured leukemic cells without any influence on the viability of normal lymphocytes. Phenothiazines and leukemia","volume":"53","author":"Zhelev","year":"2004","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1124\/jpet.119.256818_bib152","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3892\/ijo.2015.3229","article-title":"The antipsychotic drug pimozide inhibits cell growth in prostate cancer through suppression of STAT3 activation","volume":"48","author":"Zhou","year":"2016","journal-title":"Int J Oncol"},{"key":"10.1124\/jpet.119.256818_bib153","doi-asserted-by":"crossref","first-page":"e1111","DOI":"10.1038\/cddis.2014.56","article-title":"Harnessing the lysosome-dependent antitumor activity of phenothiazines in human small cell lung cancer","volume":"5","author":"Zong","year":"2014","journal-title":"Cell Death Dis"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652425905X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652425905X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.119.256818","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T10:58:00Z","timestamp":1739962680000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235652425905X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":159,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S002235652425905X"],"URL":"https:\/\/doi.org\/10.1124\/jpet.119.256818","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.735582676.793560461","asserted-by":"object"}]},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer and the Dopamine D2 Receptor: A Pharmacological Perspective","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.119.256818","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}